A
Atriva Therapeutics
0 followers
Atriva Therapeutics, founded in 2015, is a biopharmaceutical company specifically pioneering the development of host-targeting antiviral therapies set up by a team of leading scientists in viral research and seasoned industry experts.
Org chart
Stephan Stenglein
Chief Medical Officer
Martina Parat
Chief of Staff
Board & advisors
Ulrich Dauer
Chair of Advisory Board
Stephan Ludwig
Advisor
Paul Lelieveld
Advisor
Frank Hensel
Advisor
Rudolf Erlemann
Advisor
Stephan Pleschka
Scientific Advisor